Pain relief technique for patients after heart surgery
Impact of Intertransverse Process Block on Postoperative Acute Pain in Patients Undergoing Coronary Artery Bypass Grafting Via Median Sternotomy: A Prospective, Randomized Controlled Trial"
This study is testing if a pain relief technique using a special injection can help people recovering from heart surgery feel less pain and use fewer pain medications.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Konya City Hospital Academic / other |
| Locations | 1 site (Konya) |
| Trial ID | NCT06908681 on ClinicalTrials.gov |
What this trial studies
This prospective, randomized controlled trial evaluates the effectiveness of bilateral intertransverse process block (ITPB) in reducing acute postoperative pain in patients undergoing coronary artery bypass grafting (CABG) via median sternotomy. Participants will be randomly assigned to receive either ITPB with bupivacaine or a placebo saline injection before surgery. The study will assess pain scores, opioid consumption, and recovery quality during the first 24 hours after extubation. The goal is to determine if ITPB can enhance recovery and minimize opioid use in this patient population.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older scheduled for elective CABG via median sternotomy.
Not a fit: Patients undergoing emergency CABG surgery or those with certain medical conditions such as coagulopathy or hepatic failure may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative pain and opioid consumption for patients undergoing heart surgery.
How similar studies have performed: Other studies have shown promise with regional anesthesia techniques in managing postoperative pain, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Elective coronary artery bypass grafting (CABG) via median sternotomy planned * Able to provide written informed consent * Able to communicate symptoms reliably with the research team Exclusion Criteria: * Emergency CABG surgery * Infection or open wound at the injection site * Coagulopathy * Hepatic or renal failure * Reoperation cases * Incomplete or missing data
Where this trial is running
Konya
- University of Health Sciences, Konya City Hospital — Konya, Turkey (Recruiting)
Study contacts
- Study coordinator: Mustafa Aydemir
- Email: drmustafaaydemir02@gmail.com
- Phone: +905378725583
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.